Our mission at the UA Division of Pulmonary, Allergy, Critical Care and Sleep Medicine (PACCS) is to provide the best medical care to our patients in an environment that fosters patient safety, innovation, training excellence and scientific inquiry. Our division houses several clinical programs and four primary active fellowship training programs in: Pulmonary & Critical Care, Allergy & Immunology, Critical Care, and Sleep Medicine...

Sairam Parthasarathy, MD
Chief, UA Division of Pulmonary, Allergy, Critical Care & Sleep Medicine

Pulmonary, Allergy, Critical Care and Sleep Medicine

Division Overview

The Division of Pulmonary, Allergy, Critical Care and Sleep Medicine was created in 1968, two years after the opening of the University of Arizona College of Medicine – Tucson.

The inaugural division chief Benjamin Burrows, MD, an emphysema and pulmonary physiology specialist, was recruited from the University of Chicago. Dr. Burrows was a visionary and left a legacy of pulmonary translational research, initially funded by the NIH Specialized Center of Research (SCOR) in Pulmonary Diseases. He launched the first “center of excellence” at the UA, the Arizona Respiratory Center, in 1971. Headed by Fernando Martinez, MD, the center was rebranded in 2016 as the Asthma and Airway Diseases Research Center (A2DRC), with a new website unveiled in 2019. The rebranding of the A2DRC heralds a focused effort to cure asthma.

Our current division chief, Sairam Parthasarathy, MD, arrived in 2011. Prior to that, he was affiliated with the Southern Arizona VA Health Care System’s Tucson VA Medical Center as chief of research, section chief for pulmonary and critical care medicine, and head of the sleep medicine lab. He served in similar roles in Chicago before that with the Loyola University Medical Center and Edward Hines Jr. VA Hospital. Today, he also serves as medical director of the Banner – University Medical Center Tucson Center for Sleep Disorders and director of the UA Health Sciences Center for Sleep and Circadian Sciences, both of which he founded. With his research on sleep-disordered breathing and sleep apnea funded by the National Institutes of Health for more than two decades, Dr. Parthasarathy also serves as an expert advisory consultant on NIH's five-year strategic plan for sleep medicine. 

Our division now numbers more than 30 physicians and scientists. It is home to many nationally and internationally known physician-scientists pursuing breakthroughs in translational medicine to various pulmonary diseases and conditions. These include Ken Knox, MD, known for his research in HIV-related pulmonary diseases and clinical expertise in sarcoidosis, fungal diagnostics, immunologic lung disease and bronchoalveolar lavage; our Department Chair Monica Kraft, MD; and Joe G. N. “Skip” Garcia, MD, a physician-scientist on acute respiratory distress syndrome and past senior vice president, UA Health Sciences. Furthermore, our Pulmonary Services program was named among the top 50 in the nation by U.S. News & World Report in 2015-16, 2017-18 and 2018-19.


Meet Our Fellows 

See our 2019-20 fellows in allergy, critical care, pulmonary and sleep medicine (click image to enlarge):

 

News

UA-Led Study on Hyperglucagonemia, Type 2 Diabetes Picked Up by Journal of Endocrinology

The Journal of Endocrinology has published a paper with the UA’s Dr. Jennifer Stern as lead author on research that suggests the metabolic glucoregulatory disturbance in obesity that can result in type 2 diabetes may be driven by inappropriate fasting-induced regulation of glucagon, resulting in a static glucagon:insulin ratio…


ADA Awards $600K to Dr. Coletta to Study Mitochondrial Epigenetic Changes in Type 2 Diabetes Patients

Endocrinology’s Dr. Dawn Coletta received a three-year, $600,000 award from the American Diabetes Association (ADA) for a study titled “Unraveling the role of mitochondrial DNA methylation in type 2 diabetes.” With co-investigators Drs. Wayne Willis, Lawrence Mandarino and Janet Funk, this study will determine whether DNA methylation of the mitochondrial DNA impairs mitochondrial function in obese or type 2 diabetes insulin-resistant patients and could lead to therapies to address it…


Dr. Daruka Mahadevan Named Hem-Onc Chief at UT Health San Antonio, Mays Cancer Center

Dr. Daruka Mahadevan, a University of Arizona professor in the Division of Hematology and Oncology, co-leader of the Therapeutic Development Program and director of the Clinical Trials Phase I Program at the UA Cancer Center, was named chief of the Division of Hematology and Medical Oncology at the University of Texas, San Antonio, Department of Medicine and will lead that service line at the Mays Cancer Center at UT Health San Antonio. He’ll start in his new position Dec. 1…


Events

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium